NCT05467475View on ClinicalTrials.gov

A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

January 23, 2023

Study Completion Date

January 23, 2023

Conditions
Healthy
Interventions
DRUG

BI 1819479

BI 1819479

DRUG

Esomeprazole

Esomeprazole

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY